Humanizing Big Data: Recognizing the Human Aspect of Big Data

被引:2
作者
Helzlsouer, Kathy [1 ]
Meerzaman, Daoud [2 ]
Taplin, Stephen [3 ]
Dunn, Barbara K. [4 ]
机构
[1] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[2] NCI, Ctr Biomed Informat & Informat Technol, Bethesda, MD 20892 USA
[3] NCI, Ctr Global Hlth, Bethesda, MD 20892 USA
[4] NCI, Div Canc Prevent, Bethesda, MD 20892 USA
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
big data; predictive analytics; precision medicine; cancer risk prediction; clinical genetics; genomics; direct-to-consumer testing; data sharing; ETHICS; MEDICINE; HEALTH;
D O I
10.3389/fonc.2020.00186
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The term "big data" refers broadly to large volumes of data, often gathered from several sources, that are then analyzed, for example, for predictive analytics. Combining and mining genetic data from varied sources including clinical genetic testing, for example, electronic health records, what might be termed as "recreational" genetic testing such as ancestry testing, as well as research studies, provide one type of "big data." Challenges and cautions in analyzing big data include recognizing the lack of systematic collection of the source data, the variety of assay technologies used, the potential variation in classification and interpretation of genetic variants. While advanced technologies such as microarrays and, more recently, next-generation sequencing, that enable testing an individual's DNA for thousands of genes and variants simultaneously are briefly discussed, attention is focused more closely on challenges to analysis of the massive data generated by these genomic technologies. The main theme of this review is to evaluate challenges associated with big data in general and specifically to bring the sophisticated technology of genetic/genomic testing down to the individual level, keeping in mind the human aspect of the data source and considering where the impact of the data will be translated and applied. Considerations in this "humanizing" process include providing adequate counseling and consent for genetic testing in all settings, as well as understanding the strengths and limitations of assays and their interpretation.
引用
收藏
页数:6
相关论文
共 39 条
  • [1] Next-Generation Sequencing to Diagnose Suspected Genetic Disorders
    Adams, David R.
    Eng, Christine M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14) : 1353 - 1362
  • [2] Big Data for Health
    Andreu-Perez, Javier
    Poon, Carmen C. Y.
    Merrifield, Robert D.
    Wong, Stephen T. C.
    Yang, Guang-Zhong
    [J]. IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2015, 19 (04) : 1193 - 1208
  • [3] [Anonymous], 2013, JAMA-J AM MED ASSOC, V309, P1533, DOI [10.1001/jama.2013.2950, DOI 10.1001/JAMA.2013.2950]
  • [4] [Anonymous], 2014, SHARE APPROACH
  • [5] [Anonymous], Precision medicine in cancer treatment
  • [6] Clinical assessment incorporating a personal genome
    Ashley, Euan A.
    Butte, Atul J.
    Wheeler, Matthew T.
    Chen, Rong
    Klein, Teri E.
    Dewey, Frederick E.
    Dudley, Joel T.
    Ormond, Kelly E.
    Pavlovic, Aleksandra
    Morgan, Alexander A.
    Pushkarev, Dmitry
    Neff, Norma F.
    Hudgins, Louanne
    Gong, Li
    Hodges, Laura M.
    Berlin, Dorit S.
    Thorn, Caroline F.
    Sangkuhl, Katrin
    Hebert, Joan M.
    Woon, Mark
    Sagreiya, Hersh
    Whaley, Ryan
    Knowles, Joshua W.
    Chou, Michael F.
    Thakuria, Joseph V.
    Rosenbaum, Abraham M.
    Zaranek, Alexander Wait
    Church, George M.
    Greely, Henry T.
    Quake, Stephen R.
    Altman, Russ B.
    [J]. LANCET, 2010, 375 (9725) : 1525 - 1535
  • [7] The Revival of the Notes Field: Leveraging the Unstructured Content in Electronic Health Records
    Assale, Michela
    Dui, Linda Greta
    Cina, Andrea
    Seveso, Andrea
    Cabitza, Federico
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [8] Big data in pharmacogenomics: current applications, perspectives and pitfalls
    Barrot, Claire-Cecile
    Woillard, Jean-Baptiste
    Picard, Nicolas
    [J]. PHARMACOGENOMICS, 2019, 20 (08) : 609 - 620
  • [9] Burke Wylie, 2014, Curr Protoc Hum Genet, V81, DOI 10.1002/0471142905.hg0915s81
  • [10] A glossary for big data in population and public health: discussion and commentary on terminology and research methods
    Fuller, Daniel
    Buote, Richard
    Stanley, Kevin
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2017, 71 (11) : 1113 - 1117